Nanoparticle albumin-bound (NAB) technology is a promising method for anti-cancer drug delivery.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Recent Patents on Anti-Cancer Drug Discovery

• Publication date

  2009-10-31

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.2174/157489209789206869PMID 19538176
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Promising Novel Cytotoxic Agents and Combinations in Metastatic Prostate Cancer

  2008cited by this paper
• Randomized Crossover Pharmacokinetic Study of Solvent-Based Paclitaxel and nab-Paclitaxel

  2008cited by this paper
• Phase I Trial of Nanoparticle Albumin-Bound Paclitaxel in Combination with Gemcitabine in Patients with Thoracic Malignancies

  2008cited by this paper
• Phase I/II trial of weekly intravenous 130-nm albumin-bound paclitaxel as initial chemotherapy in patients with stage IV non-small-cell lung cancer.

  2008cited by this paper
• Protein nanoparticles as drug carriers in clinical medicine.

  2008cited by this paper
• Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer.

  2007cited by this paper
• Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane®) on three treatment schedules in patients with solid tumors

  2007cited by this paper
• Bevacizumab and albumin-bound paclitaxel treatment in metastatic breast cancer.

  2007cited by this paper
• Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel.

  2006cited by this paper
• Abraxane in the treatment of ovarian cancer: the absence of hypersensitivity reactions.

  2006cited by this paper
• Abraxane, a novel Cremophor-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer.

  2006cited by this paper
• Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer.

  2005cited by this paper
• An expanding role for mTOR in cancer.

  2005cited by this paper
• Phase I and pharmacokinetics trial of ABI-007, a novel nanoparticle formulation of paclitaxel in patients with advanced nonhematologic malignancies.

  2005cited by this paper
• Thiocolchicine dimers: a novel class of topoisomerase-I inhibitors.

  2005cited by this paper
• Comparative Preclinical and Clinical Pharmacokinetics of a Cremophor-Free, Nanoparticle Albumin-Bound Paclitaxel (ABI-007) and Paclitaxel Formulated in Cremophor (Taxol)

  2005cited by this paper
• Multicenter phase II trial of ABI-007, an albumin-bound paclitaxel, in women with metastatic breast cancer.

  2005cited by this paper
• Docetaxel serum protein binding with high affinity to alpha1-acid glycoprotein

  2004cited by this paper
• New targets for therapy in breast cancer: Mammalian target of rapamycin (mTOR) antagonists

  2004cited by this paper
• Fatal outcome of a hypersensitivity reaction to paclitaxel: a critical review of premedication regimens

  2004cited by this paper
• Front-Line Chemotherapy with Docetaxel and Gemcitabine Administered Every Two Weeks in Patients with Metastatic Breast Cancer: A Multicenter Phase II Study

  2004cited by this paper
• Paclitaxel and Gemcitabine, As First-Line Chemotherapy, Combined with Trastuzumab in Patients with Advanced Breast Cancer: A Phase II Study Conducted by the Hellenic Cooperative Oncology Group (HeCOG)

  2004cited by this paper
• Metabolism of taxol by human and rat liver in vitro: A screen for drug interactions and interspecies differences

  2004cited by this paper
• Carboplatin plus paclitaxel combination chemotherapy: impact of sequence of drug administration on treatment-induced neutropenia.

  2003cited by this paper
• A novel intraarterial chemotherapy using paclitaxel in albumin nanoparticles to treat advanced squamous cell carcinoma of the tongue: preliminary findings.

  2003cited by this paper
• Factors and mechanism of "EPR" effect and the enhanced antitumor effects of macromolecular drugs including SMANCS.

  2003cited by this paper
• Multicenter, randomized trial for stage IIIB or IV non-small-cell lung cancer using weekly paclitaxel and carboplatin followed by maintenance weekly paclitaxel or observation.

  2003cited by this paper
• Caveolin regulation of endothelial function.

  2003cited by this paper
• Molecular Pathway for Cancer Metastasis to Bone*

  2003cited by this paper
• Clinical significance of secreted protein acidic and rich in cystein in esophageal carcinoma and its relation to carcinoma progression

  2003cited by this paper
• Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel.

  2002cited by this paper
• Hsp90 inhibitors as novel cancer chemotherapeutic agents.

  2002cited by this paper
• Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation.

  2001cited by this paper
• Albumin uptake and transcytosis in endothelial cells in vivo induced by albumin-binding protein.

  2001cited by this paper
• Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer.

  2001cited by this paper
• Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells.

  2001cited by this paper
• High affinity binding of paclitaxel to human serum albumin.

  2001cited by this paper
• Intraarterial chemotherapy with polyoxyethylated castor oil free paclitaxel, incorporated in albumin nanoparticles (ABI‐007)

  2001cited by this paper
• Analysis of the gene expression of SPARC and its prognostic value for bladder cancer.

  2001cited by this paper
• The pharmacokinetics of a 1-h paclitaxel infusion

  2000cited by this paper
• Alterations in SPARC and VEGF immunoreactivity in epithelial ovarian cancer.

  2000cited by this paper
• Differential expression of osteonectin/SPARC during human prostate cancer progression.

  2000cited by this paper
• Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.

  2000cited by this paper
• Drug-like properties and the causes of poor solubility and poor permeability.

  2000cited by this paper
• Interaction of taxol with human serum albumin.

  2000cited by this paper
• Reversible ligand binding to human serum albumin. Theoretical and clinical aspects.

  1999cited by this paper
• Osteonectin expression correlates with clinical outcome in thin cutaneous malignant melanomas.

  1999cited by this paper
• Crystal structure of human serum albumin at 2.5 A resolution.

  1999cited by this paper
• Osteonectin promotes prostate cancer cell migration and invasion: a possible mechanism for metastasis to bone.

  1999cited by this paper
• Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: a multicenter phase II trial. Greek Breast Cancer Cooperative Group.

  1999cited by this paper
• SPARC: a potential diagnostic marker of invasive meningiomas.

  1999cited by this paper
• Activation of SPARC expression in reactive stroma associated with human epithelial ovarian cancer.

  1999cited by this paper
• Elevated expression of caveolin is associated with prostate and breast cancer.

  1998cited by this paper
• Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites

  1998cited by this paper
• Gp60 Activation Mediates Albumin Transcytosis in Endothelial Cells by Tyrosine Kinase-dependent Pathway*

  1997cited by this paper
• Pharmacokinetics of paclitaxel and carboplatin in a dose-escalating and dose-sequencing study in patients with non-small-cell lung cancer. The European Cancer Centre.

  1997cited by this paper
• The expression of the secreted protein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma.

  1997cited by this paper
• Isolation and characterization of a cell surface albumin-binding protein from vascular endothelial cells.

  1996cited by this paper
• Distribution of SPARC in normal and neoplastic human tissue.

  1995cited by this paper
• Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans.

  1995cited by this paper
• Taxol metabolism by human liver microsomes: identification of cytochrome P450 isozymes involved in its biotransformation.

  1994cited by this paper
• Selective biotransformation of taxol to 6 alpha-hydroxytaxol by human cytochrome P450 2C8.

  1994cited by this paper
• Structure of serum albumin.

  1994cited by this paper
• Cytochrome P450 3A-mediated human liver microsomal taxol 6 alpha-hydroxylation.

  1994cited by this paper
• Metabolism of taxol by human hepatic microsomes and liver slices: participation of cytochrome P450 3A4 and an unknown P450 enzyme.

  1994cited by this paper
• gp60 is an albumin-binding glycoprotein expressed by continuous endothelium involved in albumin transcytosis.

  1992cited by this paper
• Stability, compatibility, and plasticizer extraction of taxol (NSC-125973) injection diluted in infusion solutions and stored in various containers.

  1991cited by this paper
• Structure and ligand binding properties of human serum albumin.

  1990cited by this paper
• A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

  1986cited by this paper
• The location of drug binding sites in human serum albumin.

  1981cited by this paper

• Paclitaxel loaded human serum albumin nanoparticles, from batch to microfluidics: A smart manufacturing approach for nab-paclitaxel nanosimilar candidate and in vitro head-to-head comparison

  2026cites this paper
• Albumin nanocomplex of BCL-2/xL inhibitor reduced platelet toxicity and improved anticancer efficacy in myeloproliferative neoplasm and lymphoma.

  2025cites this paper
• Nanoparticle Albumin-Bound Bortezomib: Enhanced Antitumor Efficacy and Tumor Accumulation in Breast Cancer Therapy.

  2025cites this paper
• Amplifying therapeutic potential through optimization of bioavailability of poorly soluble flavonols via albumin-based nanoparticles

  2025cites this paper
• Optimized and Functionalized Carvacrol-Loaded Nanostructured Lipid Carriers for Enhanced Cytotoxicity in Breast Cancer Cells

  2025cites this paper
• Albumin-based nanoparticles: a potential and emerging oral drug delivery system

  2025cites this paper
• Clinical Applications of Cell-Specific Carriers Based on Glycosylated Albumin.

  2025cites this paper
• Preparation of Self-Assembled Human Serum Albumin Nanoparticles Decorated with Trastuzumab as a Paclitaxel Delivery System

  2025cites this paper
• Recent advances in albumin-based nanoparticle drug delivery systems for intestinal disease treatment

  2025cites this paper
• Chemoradiotherapy and nanomedicine: Drug mechanisms and delivery systems.

  2024cites this paper
• Crafting Docetaxel-Loaded Albumin Nanoparticles Through a Novel Thermal-Driven Self-Assembly/Microfluidic Combination Technology: Formulation, Process Optimization, Stability, and Bioavailability

  2024cites this paper
• Targeting Intracellular Bacteria with Dual Drug-loaded Lactoferrin Nanoparticles

  2024cites this paper
• Albumin is a reliable drug-delivering molecule: Highlighting points in cancer therapy

  2024cites this paper
• An Oral Nanomedicine Elicits In Situ Vaccination Effect against Colorectal Cancer.

  2024cites this paper
• Inflammation-Targeted Drug Delivery Strategies via Albumin-Based Systems.

  2024cites this paper
• Safety and efficacy of generic nab-paclitaxel-based therapy in Chinese patients with malignant tumors in a real-world setting: a multicenter prospective observational study

  2024cites this paper
• Preclinical Development of a Genetically Engineered Albumin‐Binding Nanoparticle of Paclitaxel

  2024cites this paper
• Advancing Tumor Therapy: Development and Utilization of Protein-Based Nanoparticles

  2024cites this paper
• Multifunctional nanoparticles encapsulating methotrexate and curcumin for holistic management of rheumatoid arthritis: in-vitro and pre-clinical assessment

  2023cites this paper
• Protein-based Nanoparticles: From Drug Delivery to Imaging, Nanocatalysis and Protein Therapy.

  2023cites this paper
• Microphysiological systems to study colorectal cancer: state-of-the-art

  2023cites this paper
• Complex formulation strategies to overcome the delivery hurdles of laptinib in metastatic breast cancer

  2023cites this paper
• Proteins and their functionalization for finding therapeutic avenues in cancer: Current status and future prospective.

  2023cites this paper
• Improving solubility of poorly water-soluble drugs by protein-based strategy: a review.

  2023cites this paper
• Challenges of nanoparticle albumin bound (nab™) technology: Comparative study of Abraxane® with a newly developed albumin-stabilized itraconazole nanosuspension.

  2023cites this paper
• Recent Advancements and Strategies for Overcoming the Blood–Brain Barrier Using Albumin-Based Drug Delivery Systems to Treat Brain Cancer, with a Focus on Glioblastoma

  2023cites this paper
• Development of Injectable Formulation of 4’-O-benzyloxycarbonyl-etoposide Derivative Based on Human Serum Albumin for the Chemotherapy of Breast Cancer

  2023cites this paper
• Protein and Peptide-based Nanoparticles as an emerging strategy to tackle cancer drug resistance

  2023cites this paper
• Enhancing chemotherapy for pancreatic cancer through efficient and sustained tumor microenvironment remodeling with a fibroblast-targeted nanosystem.

  2023cites this paper
• Lactoferrin-Conjugated Nanoparticles as New Antivirals

  2022cites this paper
• Targeted Delivery Methods for Anticancer Drugs

  2022cites this paper
• Comprehensive comparison of theranostic nanoparticles in breast cancer.

  2022cites this paper
• Inducing the formation of a colloidal albumin carrier of curcumin

  2022cites this paper
• Synergizing effects of chemodynamic therapy and chemotherapy against breast cancer by oxaliplatin-loaded polydopamine/BSA@copper ferrite

  2022cites this paper
• The evaluation of anticancer activity by synthesizing 5FU loaded albumin nanoparticles by exposure to UV light.

  2022cites this paper
• J-aggregates albumin-based NIR-II fluorescent dye nanoparticles for cancer phototheranostics

  2022cites this paper
• Preparation and Characterization of Bovine Serum Albumin Nanoparticles of Curcumin using a Chemometric Approach

  2022cites this paper
• Optimization of Benzamide Derivatives as Potent and Orally Active Tubulin Inhibitors Targeting the Colchicine Binding Site.

  2022cites this paper
• CELL INCORPORATION STUDY OF [99mTc]Tc-NAB-PACLITAXEL ON HUMAN COLORECTAL ADENOCARCINOMA CELL LINE

  2022cites this paper
• Albumin: A Multi-talented Clinical and Pharmaceutical Player

  2022cites this paper
• Fabrication of protein nanomaterials as delivery systems.

  2022cites this paper
• Lyophilization of Curcumin–Albumin Nanoplex with Sucrose as Cryoprotectant: Aqueous Reconstitution, Dissolution, Kinetic Solubility, and Physicochemical Stability

  2022cites this paper
• Effects of Surfactants on Albumin Nanoparticles

  2022cites this paper
• An Albumin-Enriched Nanocomplex Achieves Systemic Delivery of Clopidogrel Bisulfate to Ameliorate Renal Ischemia Reperfusion Injury in Rats.

  2022cites this paper
• The Development of the Innovative Synthesis Methodology of Albumin Nanoparticles Supported by Their Physicochemical, Cytotoxic and Hemolytic Evaluation

  2021cites this paper
• Peptide Modified Albumin-Paclitaxel Nanoparticles for Improving Chemotherapy and Preventing Metastasis.

  2021cites this paper
• Apoferritin and Dps as drug delivery vehicles: Some selected examples in oncology.

  2021cites this paper
• Anticancer nano-delivery systems based on bovine serum albumin nanoparticles; a critical review.

  2021cites this paper
• A Mannosylated, PEGylated Albumin as a Drug Delivery System for the Treatment of Cancer Stroma Cells

  2021cites this paper
• Lactoferrin may inhibit the development of cancer via its immunostimulatory and immunomodulatory activities (Review).

  2021cites this paper
• The Therapeutic Effect of Human Serum Albumin Dimer-Doxorubicin Complex against Human Pancreatic Tumors

  2021cites this paper
• Cancer Nanomedicine and Immune System—Interactions and Challenges

  2021cites this paper
• A novel preparative method for nanoparticle albumin-bound paclitaxel with high drug loading and its evaluation both in vitro and in vivo

  2021cites this paper
• The Uniqueness of Albumin as a Carrier in Nanodrug Delivery.

  2021cites this paper
• Lignin, lipid, protein, hyaluronic acid, starch, cellulose, gum, pectin, alginate and chitosan-based nanomaterials for cancer nanotherapy: Challenges and opportunities.

  2021cites this paper
• Drug Delivery Systems of Natural Products in Oncology

  2020cites this paper
• Albumin-bound paclitaxel and gemcitabine combination therapy in soft tissue sarcoma

  2020cites this paper
• Implication of Serum and Salivary Levels of Albumin as a Diagnostic Tool in Oral Premalignancy and Malignancy

  2020cites this paper
• Self-assembled non-covalent protein-drug nanoparticles: an emerging delivery platform for anti-cancer drugs

  2020cites this paper
• Docetaxel and its nanoformulations: how delivery strategies could impact the therapeutic outcome?

  2020cites this paper
• Lactoferrin, a unique molecule with diverse therapeutical and nanotechnological applications

  2020cites this paper
• Albumin-based nanoparticles: a promising strategy to overcome cancer drug resistance

  2020cites this paper
• Nanoparticles based on natural, engineered or synthetic proteins and polypeptides for drug delivery applications.

  2020influential citation
• The physiological characteristics of the basal microvilli microvessels in pancreatic cancers

  2020cites this paper
• Towards green nanoscience: From extraction to nanoformulation.

  2020cites this paper
• Encapsulation of epigallocatechin-3-gallate into albumin nanoparticles improves pharmacokinetic and bioavailability in rat model

  2019cites this paper
• Targeting KRAS Mutant Lung Cancer Cells with siRNA-Loaded Bovine Serum Albumin Nanoparticles

  2019cites this paper
• Albumin Based Nanoparticles for Detection of Pancreatic Cancer Cells.

  2019cites this paper
• Enhanced dissolution and oral bioavailability of praziquantel by emulsification with human serum albumin followed by spray drying.

  2019cites this paper
• Streptomycin sulfate dry powder inhalers for the new tuberculosis treatment schedule

  2019cites this paper
• Pharmacokinetics of Total and Unbound Paclitaxel After Administration of Paclitaxel Micellar or Nab-Paclitaxel: An Open, Randomized, Cross-Over, Explorative Study in Breast Cancer Patients

  2019cites this paper
• Intravenous Human Serum Albumin (HSA)-Bound Artemether Nanoparticles for Treatment of Severe Malaria

  2018cites this paper
• Cryosynthesis of Co-Crystals of Poorly Water-Soluble Pharmaceutical Compounds and Their Solid Dispersions with Polymers. The “Meloxicam–Succinic Acid” System as a Case Study

  2018cites this paper
• Chemosensitizer and docetaxel-loaded albumin nanoparticle: overcoming drug resistance and improving therapeutic efficacy.

  2018cites this paper
• Lapatinib nano-delivery systems: a promising future for breast cancer treatment

  2018cites this paper
• Evaluation of the selective toxic effect of the charge switchable diethyldithiocarbamate-loaded nanoparticles between hepatic normal and cancerous cells

  2018cites this paper
• Navigating albumin-based nanoparticles through various drug delivery routes.

  2018cites this paper
• Endolysosomal-Escape Nanovaccines through Adjuvant-Induced Tumor Antigen Assembly for Enhanced Effector CD8+ T Cell Activation.

  2018cites this paper
• Docetaxel loaded immunonanoparticles delivery in EGFR overexpressed breast carcinoma cells

  2018cites this paper
• The Medical Applications of Nanomaterials in the Central Nervous System

  2017cites this paper
• Cancer drug delivery in the nano era: An overview and perspectives

  2017cites this paper
• Targeted nanotechnologies for cancer intervention: a patent review (2010-2016)

  2017cites this paper
• Gelatin-albumin hybrid nanoparticles as matrix metalloproteinases-degradable delivery systems for breast cancer therapy.

  2017cites this paper
• Docetaxel-loaded Bovine Serum Albumin Nanoparticles Conjugated Docosahexaenoic Acid for Inhibiting Lung Cancer Metastasis to Bone.

  2017cites this paper
• Albumin micro/nanoparticles entrapping liposomes for itraconazole green formulation

  2017cites this paper
• Efficacy of an Intravenous Form of Rifapentine in a Model of Experimental Tuberculosis in Mice

  2017cites this paper
• Multiphase microfluidic synthesis of micro- and nanostructures for pharmaceutical applications

  2017cites this paper
• Thermodynamic aspects of freeze-drying

  2017cites this paper
• Biopolymers for gene delivery applications

  2017cites this paper
• The synthesis of tamoxifen-loaded albumin nanoparticles by homogenizers: Optimization and in vitro characterization

  2017cites this paper
• Preparation of human serum albumin nanoparticles using a chemometric technique

  2017cites this paper
• Novel targets for paclitaxel nano formulations: Hopes and hypes in triple negative breast cancer.

  2016cites this paper
• Albumin-Based Nanodevices as Drug Carriers.

  2016cites this paper
• Tailoring Soft Nanoparticles for Potential Application as Drug Carriers in Bladder Cancer Chemotherapy

  2016cites this paper
• Development of a More Efficient Albumin-Based Delivery System for Gambogic Acid with Low Toxicity for Lung Cancer Therapy

  2016cites this paper
• Albumin hybrid nanoparticles loaded with tyrosine kinase A inhibitor GNF-5837 for targeted inhibition of breast cancer cell growth and invasion.

  2016cites this paper
• Materials technology in drug eluting balloons: Current and future perspectives.

  2016cites this paper
• Antibody-targeted biodegradable nanoparticles for cancer therapy.

  2016cites this paper
• Use of Proteins to Increase the Aqueous Solubility of Rifapentine

  2016cites this paper
• Pharmaceutical potential of tacrolimus-loaded albumin nanoparticles having targetability to rheumatoid arthritis tissues.

  2016cites this paper